Health Canada inspection
Novartis Singapore Pharmaceutical Manufacturing PTE Ltd.: Health Canada inspection of Jun 29, 2020
Health Canada · GMP · rating C
Key facts
| Establishment | Novartis Singapore Pharmaceutical Manufacturing PTE Ltd. |
|---|---|
| City | Singapore |
| Country | Singapore |
| Program | GMP |
| Start date | Jun 18, 2020 |
| End date | Jun 29, 2020 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.